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Summary The infiltrated tissues from seven West Indian patients with HTLV-1 positive adult T cell
lymphoma/leukaemia (ATLL) have been analysed by immunocytochemical techniques for the presence of
immunoreactive parathyroid hormone-related protein (PTHrP), a hormonal mediator of humoral hypercal-
caemia ofmalignancy. Six of the seven were hypercalcaemic at some stage of the course of their disease. Four
of the six evaluable patients showed evidence of specific cellular and extracellular expression of PTHrP protein
in neoplastic tissues. This finding suggests that PTHrP may be involved in the production ofhypercalcaemia in
at least some cases of T cell lymphoma - proof of a causal relationship however must await the demonstration
of tissue release of PTHrP resulting in raised circulating hormone levels.
Adult T cell lymphoma/leukaemia (ATLL) (reviewed in Uch-
iyama, 1988; Neely, 1989) is a neoplasm of lymphocytes
presumptively caused by the human T cell lymphotropic
virus, HTLV-1, (Yamaguchi et al., 1984) and exhibiting a
characteristic morphology. It has a pronounced geographical
distribution originally being described in south-western Japan
(Uchiyama et al., 1977) and later also shown to have a
particular prevalance in Caribbean emigrants to the UK and
USA (Catovsky et al., 1982; Blayney et al., 1983; Bunn et al.,
1983; Swerdlow et al., 1984). The disease is frequently
associated with hypercalcaemia, which taken with its resis-
tance to chemotherapy, contributes to the uniformly poor
prognosis.
The aetiology of hypercalcaemia in ATLL has not been
fully elucidated. Abnormalities in parathyroid hormone, pro-
staglandin E and vitamin D metabolism have been suggested,
but investigation of a large series ofcases ofATLL has failed
to demonstrate significant abnormalities (Cohn et al., 1987;
Kiyokawa et al., 1987; Fukumoto et al., 1988). Recent
studies have implicated a role for the hypercalcaemia-assoc-
iated parathyroid hormone related protein (PTHrP) (Suva et
al., 1987; Mangin et al., 1988) in the generation of hypercal-
caemia in ATLL. Motokura et al. (1988) have demonstrated
elevated levels of PTHrP mRNA and secretion of PTHrP
from a cell line MT-2, derived from a case of ATLL. More
recently, PTHrP protein has been isolated from leukaemic
effusions in two patients with ATLL (Motokura et al., 1989)
and peripheral blood of another (Fukumoto et al., 1989). It
has also been reported that a dog lymphosarcoma, capable of
inducing hypercalcaemia upon transplantation (Weir et al.,
1988), has raised PTHrP mRNA levels.
In this study we have localised PTHrP in ATLL by
immunocytochemical techniques using a series of antibodies
to synthetic peptides derived from the N-terminal and C-
terminal segments of PTHrP.
from records in the ICRF Medical Oncology Unit, St. Bar-
tholomew's Hospital and reviewed by one of us (M.A.H.).
The diagnostic criteria for the study included generalised
lymphoid or tissue infiltration with lymphoblasts characteris-
tic of- ATLL (Uchiyama et al., 1988; Neely, 1989); a leu-
kaemic marrow and blood picture involving cells of a similar
morphology; the presence of serum HTLV-1 antibodies;
serum Ca"+ levels measured at least once; and biopsy mat-
erial available for further study. Some of the pertinant
clinical and laboratory features of the seven cases are sum-
marised in Table I.
Standard histopathology, formalin-fixed wax-embedded,
biopsy material was used for immunohistological analysis.
All was archival and had not been prepared especially for the
study; of note, tissue fixation times (ideally less than 24 h for
detection of PTHrP) may have been prolonged, particularly
with the marrow trephine biopsy samples. All available
biopsy tissue was studied from each case, including multiple
tissue samples from five of the patients.
Antibodies
Rabbit antisera to synthetic PTHrP peptides - N-terminal
PTHrP (1-34), and C-terminal PTHrP (107-141) - were
prepared as previously described by us (Danks et al., 1989;
1990) and used without further purification and at optimal
dilutions (between 1:40 and 1:200 according to the antiserum
batch used) assessed by titration on sections of normal skin
and squamous carcinoma of the lung. Preimmune rabbit
serum or irrelevant primary antibodies (to HIV-1 peptides)
were used as negative control 'antisera'. Other controls
consisted of omission of any of the other stages of the
immunoperoxidase technique and inhibition of immunolog-
ical reactivity of (positive) antisera by preincubation with
cognate peptide (1 mg ml-' overnight at 4°C).
Materials and methods
Patients and biopsy material
Seven patients with the clinical, haematological and histo-
pathological features of ATLL syndrome were identified
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Control tissues
Positive control tissues were included with each run of test
samples. They were either normal skin biopsies (which show-
ed characteristic staining of the keratinocyte layer (Danks et
al., 1989; Hayman et al., 1989)) or tissue from squamous
carcinomata of the lung, which showed epithelial staining
(Danks et al., 1989) (results not shown). We have previously
demonstrated that normal foetal lymphoid tissues (spleen,
thymus (Moseley et al., in press)) and lymph node from cases
of non-ATLL Non-Hodgkin's lymphoma (Danks et al.,
1989) fail to stain with antisera to PTHrP peptides.
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Table I Carribean T-cell lymphoma/leukaemia (ATLL): patients details, calcium levels and tissue PTHrP expression
PTHrP
Immunoreactivity
with PTHrP
'Lymphade- Serum calcium Tissues (1-34)
Patient Age/Sex nopathy' 'Leukaemia' HTLV-I Ab Presentation Maximnum examinedt antibody*
SG 45/F Cervical No + 3.12 3.12 Lymph node + + + (variable)
MH 49/F Generalised Yes + 2.50 3.35 Lympho node **
(trephine)
JT 21/F Generalised Yes + 3.21 3.21 Lymph node
(trephine)
CM 31/F Gut No + 2.55 3.35 Gut,
lymphoma (trephine)
FB 48/M Generalised Yes + 3.72 4.64 Lymph node + +
(trephine)
CP 44/M Generalised No + 2.44 2.44 Lymph node + + +
PG 40/F Cervical, No + 3.68 3.72 Lymph node + (variable)
skin (trephine)
[Normal range 2.20-2.67
mmol.I'J]
tSee text for comments on staining of bone marrow trephine biopsies. *Similar results obtained with antiserum to the PTHrP
C-terminal peptide. **High background non-specific staining - see text.
Immunohistological techniques
Indirect immunoperoxidase or peroxidase-antiperoxidase (PAP)
staining of dewaxed test and control tissue sections was
carried out as detailed before (Danks et al., 1989; Hayman et
al., 1989). Control antisera and tissues were included and
allowed the interpretation of tissue staining (read indepen-
dently by three observors) on an arbitary scale: (negative or
background non-specific staining only) to + + + (strongly
positive cytoplasmic and/or extracellular and connective tis-
sue staining).
Results
Clinical andmorphologicalfeatures
Seven patients (five female and two male West Indians of
ages 21-49 years), who had the typical features of Caribbean
ATLL syndrome, have been studied (see Table I). All had
localised or general lymphoid organ (and in two, extranodal)
infiltration and in three the disease undertook a leukaemic
course. Antibodies to the HTLV-1 retrovirus were detected in
serum from each case. Tissue biopsy (lymph node, skin, gut
and bone marrow trephine) and marrow morphology was
characteristic of ATLL (Uchiyama, 1988; Neely, 1989) show-
ing proliferation of pleomorphic neoplastic lymphoblasts of
T cell immunophenotype with typical lobulated nuclear out-
line (for example, see Figure 1); the clinical and immuno-
pathological features of four of the cases have been reported
previously (Swerdlow et al., 1984). Hypercalcaemia was a
prominent feature of this group of patients: four (57%) had
hypercalcaemia at presentation (mean serum Ca`+ 3.03
mmol.l') and all but one (86%) at some stage of the short
clinical course of their disease (mean maximum serum
Ca++ = 3.40 mmol.l l- for the group).
Immunocytochemical demonstration ofPTHrP in lymphoid
tissuefrom patients with ATLL
No staining of patient tissue was seen if any of the immuno-
peroxidase reaction steps were omitted, nor if primary anti-
body was substituted with wash medium or an irrelevant
antiserum. Immune anti-PTHrP peptide sera (to N- and C-
terminal regions) reacted strongly with positive control tis-
sues (allowing optimal antibody dilutions to be found) and
failed to react with a range of tissues which did not express
PTHrP, including foetal and adult lymphohaemopoietic or-
gans (Danks et al., 1989; Moseley et al., in press) (data not
shown). The reactivity of the antisera was blocked (although
not totally) by preincubation with high concentrations of
cognate peptide.
Tissue was examined from all seven patients. Of these, one
(MH) gave an unacceptably high level of non-specific stain-
ing in all samples tested and the positive staining for PTHrP
was considered unreliable - for this reason data is presented
from the remaining six evaluable cases.
Specific cellular and/or extracellular connective tissue stain-
ing was seen using both immune antisera (maximal staining
being found with the N-terminal anti-PTHrP (1-34) serum) in
all infiltrated tissues from four of the patients (summarised
in Table I and illustrated in Figure 1). No PTHrP was found
in any of the trephine biopsies available from five of the
cases, despite morphologically detectable tumour infiltration
in three; it was likely that prolonged fixation and decalci-
fication affected PTHrP immunoreactivity, a problem pre-
viously encountered.
PTHrP expression was mainly cytoplasmic in tumour cells
in three of the four positive cases (F.B., C.P., P.G.) and
varied from weakly (Figure lb) to strongly positive (Figure
ig); the level of immunoreactivity to C-terminal PTHrP
antisera was generally lower but proportional (see Figure lh)
to that seen with N-terminal reagents. In one case (S.G.) the
distribution of PTHrP was mainly, though not exclusively,
extracellular and connective tissue-associated (connective tis-
sue staining shown in Figure ld and area of cellular staining
in Figure le); again this distribution was reflected, but at a
lower level, with the anti-C-terminal PTHrP antiserum (not
shown).
No clear correlation was found in this small group of
patients between the degree or type of PTHrP staining and
the level of serum Ca"+ at or after patient presentation.
Discussion
This study demonstrates the presence of PTHrP in the neo-
plastic tissues of the majority of cases of HTLV-1 positive
'Caribbean' lymphoma, ATLL, a disease known to have a
strong association with hypercalcaemia. All but one patient
were hypercalcaemic at some stage of their disease. In four
cases there was good immunological evidence for the expres-
sion of PTHrP protein. Antisera to peptides from two seg-
ments of the PTHrP protein reacted, albeit to a different
extent, with tumour cells and extracellular structures in infil-
trated tissues.
A variety of mechanisms have been proposed to account
for the development of abnormal calcium metabolism and
hypercalcaemia in ATLL. Abnormalities in parathyroid hor-
mone, vitamin D, prostaglandin E and tumour necrosis fac-PTHRP IN HTLV-1 T CELL LYMPHOMA 747
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Figure 1 Photomicrographs of lymph node sections stained with anti-PTHrP antisera by immunoperoxidase technique. a, c, f:
negative controls from patients (P.G., S.G., C.P.), respectively. b, d, e, g: anti-PTHrP (1-34) peptide antiserum showing: weak
staining (b, patient P.G.), extensive extracellular and connective tissue staining with areas ofcellular staining (d and e, patient S.G.)
and strong intracellular expression of PTHrP (g, patient C.P.). h: section of lymph node from patient (C.P.) stained with
anti-PTHrP C-terminal peptide serum (compare with g). (All magnified x 200 except (e), x 100).
tor a metabolism have all been proposed (Cohn et al., 1987;
Kiyokawa et al., 1987; Fukumoto et al., 1988; Adams et al.,
1989; Matsuda et al., 1990). Recent studies have suggested a
role for PTHrP, a new parathyroid hormone-like protein
(Suva et al., 1987; Mangin et al., 1988) which is involved in
normal calcium homeostasis in the foetus and implicated in
the development of humoral hypercalcaemia of malignancy
syndrome seen associated with epithelial tumours (Ikeda et
al., 1988; Danks et al., 1989; Burtis et al., 1990; and reviewed
in Martin & Suva, 1989; Kelly & Eisman, 1989). Thus,
HTLV-1 positive T cell lines and tissue from three cases of
ATLL expressed PTHrP mRNA and bioactive PTHrP was
isolated from cells or conditioned media (Motokura et al.,
1988, 1989; Fukumoto et al., 1989). Taken with our immuno-
histochemical data we can conclude that PTHrP protein, at
least in some cases of ATLL, can be synthesised by these
tumours. However, there was no definite evidence in this
small series for a correlation between the extent of PTHrP
staining and the degree of hypercalcaemia; indeed, one
PTHrP-positive case was normocalcaemic, although abnor-
mal calcium metabolism might have still been present (Fuku-
moto et al., 1988). Thus, a pathogenetic relationship between
tumour synthesis of PTHrP and induction of hypercalcaemia
remains to be proven and will await improvements in the
serum assay for this hormone (Burtis et al., 1990). The
abnormal localisation of PTHrP in a second neoplastic tissue
in association with hypercalcaemia would, though, support
the contention that PTHrP is mechanistically involved in the
development of hypercalcaemia in lymphoma.
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